World Health Organization. (2019). International Classification of Diseases, 10th Revision (ICD-10). Geneva: WHO Press.
[2]
American College of Rheumatology. (2021). Guidelines for the Management of Connective Tissue Disorders. Arthritis & Rheumatology, 73(4), 567-589.
[3]
Majithia, V., & Geraci, S. A. (2017). Rheumatoid arthritis: diagnosis, management, and comorbidities. The American Journal of Managed Care, 23(7), 215-224.
[4]
Kucharz, E. J. (2018). The Collagens: Biochemistry and Pathophysiology. Berlin: Springer-Verlag.
[5]
Kelley, J. V., & Firestein, G. S. (2018). Kelley and Firestein's Textbook of Rheumatology (10th ed.). Philadelphia: Elsevier.
[6]
Harrison's Principles of Internal Medicine, 20th Edition. (2018). New York: McGraw-Hill Education.
[7]
Indonesian Rheumatology Association. (2020). Panduan Praktik Klinis Penyakit Rematik di Indonesia. Jakarta: PB PERDOSRI.
[8]
Miller, M. L., & Vleugels, R. A. (2021). Clinical manifestations of systemic sclerosis. UpToDate. Retrieved from https://www.uptodate.com
[9]
Grahovac, T., & SδΈζη½, D. (2018). Connective tissue disorders: Pathophysiology and therapeutic targets. Pharmacological Research, 134, 85-99.
[10]
Sherman, A. L., & Ojeda-Correal, G. (2019). Rehabilitation of connective tissue disorders. Physical Medicine and Rehabilitation Clinics, 30(2), 345-367.